Bruker

Bruker

BRKR· Manufacturing· Fiscal year ends in December

CEO pay in FY2025Stock -19.6% in FY2025

Frank H. Laukien, Ph.D. is the CEO of Bruker and was paid $4.7M in FY2025 (Dec), down 15%.

Pay$100 in the stock at the end of FY20 → $77
CEO pay is from each Bruker proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives5

See all
  1. 1Frank H. Laukien, Ph.D.FY2025
  2. 2Mark R. Munch, Ph.D.FY2025
  3. 3Gerald N. HermanFY2025
  4. 4Juergen W. SregaFY2025
  5. 5Falko BusseFY2025

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Bruker paid its 5 named executives $11.7M in total in FY2025 (Dec). CEO Falko Busse was paid $1.4M of that.

Name
Frank H. Laukien, Ph.D.Chairman, President and Chief Executive Officer
Mark R. Munch, Ph.D.Executive Vice President & President, Bruker NANO Group
Gerald N. HermanExecutive Vice President and Chief Financial Officer
Juergen W. SregaPresident, Bruker CALID Group
Falko BussePh.D. President, Bruker BioSpin Group

of each named executive, from the Summary Compensation Table of each proxy.

Peers15

See all

The FY2025 (Dec) proxy of Bruker names 15 peer companies for pay. Among Bruker and these peers, CEO pay was the lowest of 11 and total shareholder return was 6th highest of 11.

11th highest of 11in Bruker and its pay peers, FY2025 (Dec) by CEO pay:

$4.7M$15.4M

6th highest of 11in Bruker and its pay peers, FY2025 (Dec) by total shareholder return:

$36$301

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.

Activity

Filings6

See all
Proxy statementDEF 14AApr 10, 2026FY2025
Annual report10-KFeb 27, 2026FY2025
Proxy statementDEF 14AApr 11, 2025FY2024
Annual report10-KMar 3, 2025FY2024
Proxy statementDEF 14AApr 19, 2024FY2023
Annual report10-KFeb 29, 2024FY2023